This week, three team members of the Alpha1 MZ Foundation will visit the European Parliament. They have been invited by ELPA, the European Liver Patients’ Association. The mission of the Foundation is to raise awareness of the significant impact of Alpha-1 Antitrypsin Deficiency (MZ genotype) on European GDP and public health.
Click here to read our mission statement.
We will keep you posted!
